Güncel Gönderiler: Araştırma Çıktıları | Web Of Science

Toplam kayıt 8594, listelenen: 41-60

    • Is diet partly responsible for differences in COVID-19 death rates between and within countries? 

      Bousquet, J; Anto, JM; Iaccarino, G; Czarlewski, W; Haahtela, T; Anto, A; Akdis, CA; Blain, H; Canonica, GW; Cardona, V; Cruz, AA; Illario, M; Ivancevich, JC; Jutel, M; Klimek, L; Kuna, P; Laune, D; Larenas-Linnemann, D; Mullol, J; Papadopoulos, NG; Pfaar, O; Samolinski, B; Valiulis, A; Yorgancioglu, A; Zuberbier, T (MAY 27)
      Reported COVID-19 deaths in Germany are relatively low as compared to many European countries. Among the several explanations proposed, an early and large testing of the population was put forward. Most current debates on ...

    • Familial Mediterranean Fever Mutation Analysis in Pediatric Patients With Inflammatory Bowel Disease: A Multicenter Study 

      Urganci, N; Ozgenc, F; Kuloglu, Z; Yuksekkaya, H; Sari, S; Erkan, T; Onal, Z; Caltepe, G; Akcam, M; Arslan, D; Arslan, N; Artan, R; Aydogan, A; Balamtekin, N; Baran, M; Baysoy, G; Cakir, M; Dalgic, B; Dogan, Y; Durmaz, O; Ecevit, C; Eren, M; Gokce, S; Gulerman, F; Gurakan, F; Hizli, S; Isik, I; Kalayci, AG; Kansu, A; Kutlu, T; Karabiber, H; Kasirga, E; Kutluk, G; Hosnut, FO; Ozen, H; Ozkan, T; Ozturk, Y; Soylu, OB; Tutar, E; Tumgor, G; Unal, F; Ugras, M; Ustundag, G; Yaman, A (MAR)
      Background: the aim of the study was to evaluate familial Mediterranean fever (FMF) mutation analysis in pediatric patients with inflammatory bowel disease (IBD). The relation between MEFV mutations and chronic inflammatory ...

    • The predictors of COVID-19 mortality in a nationwide cohort of Turkish patients 

      Kokturk, N; Babayigit, C; Kul, S; Cetinkaya, PD; Nayci, SA; Baris, SA; Karcioglu, O; Aysert, P; Irmak, I; Yuksel, AA; Sekibag, Y; Toprak, OB; Azak, E; Mulamahmutoglu, S; Cuhadaroglu, C; Demirel, A; Kerget, B; Ketencioglu, BB; Ozger, HS; Ozkan, G; Yuce, ZT; Ergan, B; Oguz, VA; Kilinc, O; Ercelik, M; Ciftci, TU; Alici, O; Temel, EN; Ataoglu, O; Aydin, A; Bahcetepe, DC; Gullu, YT; Fakili, F; Deveci, F; Kose, N; Tor, MM; Gunluoglu, G; Altin, S; Turgut, T; Tuna, T; Ozturk, O; Dikensoy, O; Gulhan, PY; Basyigit, I; Boyaci, H; Oguzulgen, IK; Borekci, S; Gemicioglu, B; Bayraktar, F; Elbek, O; Hanta, I; Okur, HK; Sagcan, G; Uzun, O; Akgun, M; Altinisik, G; Dursun, B; Edis, EC; Gulhan, E; Eyuboglu, FO; Gultekin, O; Havlucu, Y; Ozkan, M; Sakar, A; Sayiner, A; Kalyoncu, AF; Itil, O; Bayram, H (SEP 5)

    • Turkish Guideline for Diagnosis and Treatment of Allergic Rhinitis (ART) 

      Ecevit, MC; Ozcan, M; Can, IH; Tatar, EC; Ozer, S; Esen, E; Atan, D; Gode, S; Elsurer, C; Eryilmaz, A; Coskun, BU; Yazici, ZM; Dinc, ME; Ozdogan, F; Gunhan, K; Bilal, N; Korkut, AY; Kasapoglu, F; Turk, B; Server, EA; Celebi, OO; Simsek, T; Kum, RO; Adali, MK; Eren, E; Aslier, NGY; Bayindir, T; Cetin, AC; Goker, AE; Guvenc, IA; Koseoglu, S; Ozler, GS; Sahin, E; Yilmaz, AS; Gune, C; Yildirim, GA; Oca, B; Durmusoglu, M; Kantekin, Y; Ozmen, S; Kubat, GO; Sanal, SK; Altuntas, EE; Selcuk, A; Yazici, H; Baklaci, D; Yaylaci, A; Hanci, D; Dogan, S; Fidan, V; Uygur, K; Keles, N; Cingi, C; Topuz, B; Canakcioglu, S; Onerci, M (MAY)
      Object: To prepare a national guideline for Oto-rhinolaryngologist who treat allergic rhinitis patients Methods: The study was conducted by three authors, namely the writing support team. The support team made the study ...

    • Effect of Impairment on the Prevalence and Comorbidities of Attention Deficit Hyperactivity Disorder in a National Survey: Nation-Wide Prevalence and Comorbidities of ADHD 

      Ercan, ES; Unsel-Bolat, G; Tufan, AE; Demirkaya, SK; Bilac, O; Celik, G; Kilic, BG; Ardic, UA; Sapmaz, SY; Aksu, H; Tahiroglu, AY; Karacetin, G; Tural, U; Aktepe, E; Arman, AR; Basgul, S; Coskun, M; Dursun, OB; Durukan, I; Fis, NP; Gencoglan, S; Gokcen, C; Gokten, ES; Gorker, I; Gormez, V; Gundogdu, OY; Hesapcioglu, ST; Kandemir, H; Mutluer, T; Nasiroglu, S; Ozcan, O; Sahin, N; Toros, F; Yazici, IP; Yazici, KU; Yulaf, Y; Yuksel, T; Bilgic, A; Altun, H; Akdemir, D; Mazlum, B; Memik, NC; Ozdemir, DF; Uneri, O; Unal, F (MAR)
      Objective: This study aimed to determine the prevalence and comorbidities of attention-deficit hyperactivity disorder (ADHD) by evaluating a large-scale nation-wide sample of children. Method: The inclusion criterion was ...

    • Prevalence, comorbidities and mediators of childhood anxiety disorders in urban Turkey: a national representative epidemiological study 

      Mutluer, T; Gorker, I; Akdemir, D; Ozdemir, DF; Ozel, OO; Vural, P; Tufan, AE; Karacetin, G; Arman, AR; Fis, NP; Demirci, E; Ozmen, S; Hesapcioglu, ST; Oztop, D; Tural, U; Aktepe, E; Aksu, H; Ardic, UA; Basgul, S; Bilac, O; Coskun, M; Celik, GG; Demirkaya, SK; Dursun, OB; Durukan, I; Fidan, T; Gokcen, C; Gormez, V; Gundogdu, OY; Herguner, S; Kandemir, H; Kilic, BG; Kilincaslan, A; Nasiroglu, S; Sapmaz, SY; Sahin, N; Tahiroglu, AY; Toros, F; Unal, F; Yazici, IP; Yazici, KU; Isik, U; Ercan, ES
      Purpose The aim of this study is to evaluate the prevalence of anxiety disorders, its correlation with sociodemographic characteristics, its comorbidities with other psychiatric disorders and its predictors in school-aged ...

    • The impact of a csDMARD in combination with a TNF inhibitor on drug retention and clinical remission in axial spondylarthritis 

      Nissen, M; Delcoigne, B; Di Giuseppe, D; Jacobsson, L; Hetland, ML; Ciurea, A; Nekvindova, L; Iannone, F; Akkoc, N; Sokka-Isler, T; Fagerli, KM; Santos, MJ; Codreanu, C; Pombo-Suarez, M; Rotar, Z; Gudbjornsson, B; Van der Horst-Bruinsma, I; Loft, AG; Moller, B; Mann, H; Conti, F; Cetin, GY; Relas, H; Michelsen, B; Ribeiro, PA; Ionescu, R; Sanchez-Piedra, C; Tomsic, M; Geirsson, AJ; Askling, J; Glintborg, B; Lindstrom, U (DEC)
      Objectives Many axial spondylarthritis (axSpA) patients receive a conventional synthetic DMARD (csDMARD) in combination with a TNF inhibitor (TNFi). However, the value of this co-therapy remains unclear. The objectives ...

    • Efficacy and safety of folfiri plus aflibercept in second-line treatment of metastatic colorectal cancer: Real-life data from Turkish oncology group 

      Erol, C; Sendur, MAN; Bilgetekin, I; Garbioglu, DB; Hamdard, J; Akbas, S; Hizal, M; Arslan, C; Sevinc, A; Kucukarda, A; Erdem, D; Kahraman, S; Cakir, E; Demirkiran, A; On, S; Dogan, I; Erdogan, AP; Koca, S; Kubilay, P; Eren, OO; Cilbir, E; Celik, E; Araz, M; Ozyukseler, DT; Yildirim, ME; Bahceci, A; Taskaynatan, H; Oyman, A; Deniz, GI; Menekse, S; Kut, E; Gulmez, A; Sakin, A; Nayir, E; Acar, R; Sen, E; Inal, A; Turhal, S; Kaya, AO; Paydas, S; Tastekin, D; Hacibekiroglu, I; Cincin, I; Bilici, A; Mandel, NM; Dede, DS; Akinci, MB; Oksuzoglu, B; Uncu, D; Yalcin, B; Artac, M (DEC)
      Aims: The addition of aflibercept to the fluorouracil and irinotecan (FOLFIRI) regimen significantly improved clinical outcomes in patients with metastatic colorectal cancer (CRC) previously treated with oxaliplatin. We ...

    • The predictors of COVID-19 mortality in a nationwide cohort of Turkish patients 

      Kokturk, N; Babayigit, C; Kul, S; Cetinkaya, PD; Nayci, SA; Baris, SA; Karcioglu, O; Aysert, P; Irmak, I; Yuksel, AA; Sekibag, Y; Toprak, OB; Azak, E; Mulamahmutoglu, S; Cuhadaroglu, C; Demirel, A; Kerget, B; Ketencioglu, BB; Ozger, HS; Ozkan, G; Ture, Z; Ergan, B; Oguz, VA; Kilinc, O; Ercelik, M; Ciftci, TU; Alici, O; Temel, EN; Ataoglu, O; Aydin, A; Bahcetepe, DC; Gullu, YT; Fakili, F; Deveci, F; Kose, N; Tor, MM; Gunluoglu, G; Altin, S; Turgut, T; Tuna, T; Ozturk, O; Dikensoy, O; Gulhan, PY; Basyigit, I; Boyaci, H; Oguzulgen, IK; Borekci, S; Gemicioglu, B; Bayraktar, F; Elbek, O; Hanta, I; Okur, HK; Sagcan, G; Uzun, O; Akgun, M; Altinisik, G; Dursun, B; Edis, EC; Gulhan, E; Eyuboglu, FO; Gultekin, O; Havlucu, Y; Ozkan, M; Coskun, AS; Sayiner, A; Kalyoncu, AF; Itil, O; Bayram, H (JUL)
      The COVID-19-related death rate varies between countries and is affected by various risk factors. This multi-center registry study was designed to evaluate the mortality rate and the related risk factors in Turkey. We ...

    • SARS-CoV-2 seropositivity among pediatric health care personnel after the first peak of the pandemic: nationwide surveillance in Turkey 

      Oygar, PD; Buyukcam, A; Bal, ZS; Dalgic, N; Bozdemir, SE; Karbuz, A; Cetin, BS; Kara, Y; Cetin, C; Hatipoglu, N; Uygun, H; Aygun, FD; Torun, SH; Okur, DS; Ciftdogan, DY; Kara, TT; Yahsi, A; Ozer, A; Demir, SO; Akkoc, G; Turan, C; Sali, E; Sen, S; Erdeniz, EH; Kara, SS; Emiroglu, M; Erat, T; Akturk, H; Gurlevik, SL; Sutcu, M; Aydin, ZGG; Atikan, BY; Yesil, E; Guner, G; Celebi, E; Efe, K; Isancli, DK; Durmus, HS; Tekeli, S; Karaaslan, A; Bulbul, L; Almis, H; Kaba, O; Keles, YE; Yazicioglu, B; Oguz, SB; Ovali, HF; Dogan, HH; Celebi, S; Cakir, D; Karasulu, B; Alkan, G; Yenidogan, I; Gul, D; Kucukalioglu, BP; Avcu, G; Kukul, MG; Bilen, M; Yasar, B; Ustun, T; Kilic, O; Akin, Y; Cebeci, SO; Bucak, IH; Yanartas, MS; Sahin, A; Arslanoglu, S; Elevli, M; Coban, R; Oz, SKT; Hatipoglu, H; Erkum, IT; Turgut, M; Demirbuga, A; Ozcelik, T; Ciftci, D; Sari, EE; Akkus, G; Hatipoglu, SS; Dinleyici, EC; Hacimustafaoglu, M; Ozkinay, F; Kurugol, Z; Cengiz, AB; Somer, A; Tezer, H; Kara, A (DEC)
      Background: Understanding SARS-CoV-2 seroprevalence among health care personnel is important to ex-plore risk factors for transmission, develop elimination strategies and form a view on the necessity and frequency of ...

    • COVID-19 Pandemic and the Global Perspective of Turkish Thoracic Society 

      Kokturk, N; Itil, BO; Altinisik, G; Adiguzel, N; Akgun, M; Akyildiz, L; Altin, S; Arikan, H; Ates, G; Ay, P; Aykac, N; Babayigit, C; Bostan, P; Cinel, G; Calisir, HC; Celik, P; Cetinkaya, PD; Dagli, E; Demir, AU; Demir, C; Dikensoy, O; Edis, EC; Elbek, O; Erdinc, M; Ergan, B; Eyuboglu, AFO; Gemicioglu, B; Goksel, T; Gulhan, E; Gultekin, O; Gurkan, CG; Gurgun, A; Havlucu, Y; Basoglu, OK; Karakurt, S; Karkurt, Z; Kilinc, O; Kocabas, A; Kul, S; Musellim, B; Nayci, S; Ozkan, M; Pinarer, O; Salturk, C; Sandal, A; Sayiner, A; Sen, E; Simsek, GO; Karadag, BT; Akyil, FT; Toreyin, ZN; Ucan, ES; Kucuk, FCU; Varol, A; Yasin, Y; Yildiz, T; Yorgancioglu, AA; Bayram, H (NOV)
      It has been more than 3 months now since the first case of COVID-19 was reported in Turkey. Globally, the number of confirmed cases and deaths reached 9,653,048 and 491,128 respectively, as reported by 216 countries by ...

    • COVID-19 IN PEDIATRIC NEPHROLOGY CENTERS IN TURKEY 

      Bakkaloglu, SA; Atikel, YO; LeventoGlu, E; Nalcacioglu, H; Dursun, I; PoyrazoGlu, H; Dursun, H; Yildirim, ZY; Yildiz, N; Aksoy, GK; Akman, S; Tasdemir, M; Bilge, I; Celakil, M; Kilic, BD; Selcuk, SZ; Canpolat, N; Cakici, EK; Ozlu, SG; Tulpar, S; Yuksel, S; Atmis, B; Doven, SS; Taner, S; Ertan, P; Kavaz, A; Bayram, MT; Kalyoncu, M; GUlleroGlu, K; Kabasakal, C; Demir, BK; Cicek, RY; Donmez, O; Kara, A; Yavascan, O; Ozcelik, G; Yildirim, DG; Guler, MA; Sonmez, F; Topaloglu, R; Alpay, H (OCT)

    • Predictors of ASDAS-CRP inactive disease in axial spondyloarthritis during treatment with TNF-inhibitors: Data from the EuroSpA collaboration 

      Ornbjerg, LM; Linde, L; Georgiadis, S; Rasmussen, SH; Lindstrom, U; Askling, J; Michelsen, B; Di Giuseppe, D; Wallman, JK; Pavelka, K; Zavada, J; Nissen, MJ; Jones, GT; Relas, H; Pirila, L; Tomsic, M; Rotar, Z; Geirsson, AJ; Gudbjornsson, B; Kristianslund, EK; Horst-Bruinsma, IV; Loft, AG; Laas, K; Iannone, F; Corrado, A; Ciurea, A; Santos, MJ; Santos, H; Codreanu, C; Akkoc, N; Gunduz, OS; Glintborg, B; Ostergaard, M; Hetland, ML (OCT)
      Objectives: In patients with axial spondyloarthritis (axSpA) initiating their first tumor necrosis factor alpha-inhibitor (TNFi), we aimed to identify common baseline predictors of Ankylosing Spondylitis Disease Activity ...

    • The association of antiviral drugs with COVID-19 morbidity: The retrospective analysis of a nationwide COVID-19 cohort 

      Babayigit, C; Kokturk, N; Kul, S; Cetinkaya, PD; Nayci, SA; Baris, SA; Karcioglu, O; Aysert, P; Irmak, I; Yuksel, AA; Sekibag, Y; Toprak, OB; Azak, E; Mulamahmutoglu, S; Cuhadaroglu, C; Demirel, A; Kerget, B; Ketencioglu, BB; Ozger, HS; Ozkan, G; Ture, Z; Ergan, B; Oguz, VA; Kilinc, O; Ercelik, M; Ciftci, TU; Alici, O; Temel, EN; Ataoglu, O; Aydin, A; Bahcetepe, DC; Gullu, YT; Fakili, F; Deveci, F; Kose, N; Tor, MM; Gunluoglu, G; Altin, S; Turgut, T; Tuna, T; Ozturk, O; Dikensoy, O; Gulhan, PY; Basyigit, I; Boyaci, H; Oguzulgen, IK; Borekci, S; Gemicioglu, B; Bayraktar, F; Elbek, O; Hanta, I; Okur, HK; Sagcan, G; Uzun, O; Akgun, M; Altinisik, G; Dursun, B; Edis, EC; Gulhan, E; Eyuboglu, FO; Gultekin, O; Havlucu, Y; Ozkan, M; Coskun, A; Sayiner, A; Kalyoncu, AF; Itil, O; Bayram, H (AUG 31)
      Background and objectivesAlthough several repurposed antiviral drugs have been used for the treatment of COVID-19, only a few such as remdesivir and molnupiravir have shown promising effects. The objectives of our study ...

    • Efficacy and Safety of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia: Retrospective Analysis of Real-Life Data 

      Tombak, A; Tanrikulu, FP; Durusoy, SS; Dincyurek, HD; Kaya, E; Umit, EG; Yavasoglu, I; Mehtap, O; Deveci, B; Ozcan, MA; Terzi, H; Okay, M; Sayinalp, N; Yilmaz, M; Okan, V; Kizikli, A; Ozcan, O; Cetin, G; Demircioglu, S; Aydogdu, I; Saydam, G; Davulcu, EA; Ilhan, G; Ucar, MA; Ozet, G; Akpinar, S; Turgut, B; Berber, I; Kurtoglu, E; Sonmez, M; Batur, DS; Yildirim, R; Ozkocamaz, V; Gunes, AK; Sahip, B; Ertop, S; Akay, OM; Basturk, A; Dogu, MH; Akdeniz, A; Unal, A; Seyhanli, A; Gurkan, E; Cekdemir, D; Ferhanoglu, B (2021)
      Objective: This study aimed to retrospectively evaluate the efficacy, safety, and survival outcome of single-agent ibrutinib therapy in chronic lymphocytic leukemia patients. Materials and Methods: A total of 136 patients ...

    • Real-life comparison of afatinib and erlotinib in non-small cell lung cancer with rare EGFR exon 18 and exon 20 mutations: a Turkish Oncology Group (TOG) study 

      Gursoy, P; Tatli, AM; Erdem, D; Goker, E; Celik, E; Demirci, NS; Sakin, A; Atci, MM; Bayram, E; Telli, TA; Bilgin, B; Bilici, A; Akangunduz, B; Balli, S; Demirkazik, A; Selcukbiricik, F; Menekse, S; Cavdar, E; Ozturk, A; Bekmez, ET; Turhal, S; Kilickap, S; Yildirim, HC; Oyan, B; Aksoy, A; Turkoz, FP; Kut, E; Katgi, N; Sakalar, T; Akyol, M; Ellez, HI; Topcu, A; Erdogan, AP; Pilanci, KN; Hedem, E; Arak, H; Akdeniz, N; Alan, O; Yapar, B; Nart, D; Yumuk, PF
      Objectives To compare the survival of first- and second-generation tyrosine kinase inhibitors (TKIs) in patients with rare EGFR exon 18 and exon 20 mutation-positive non-small cell lung cancer (NSCLC). Materials and methods ...

    • URINARY HSP70 IMPROVES DIAGNOSTIC ACCURACY FOR URINARY TRACT INFECTION IN CHILDREN: UTILISE STUDY 

      Yilmaz, A; Afonso, AC; Akil, I; Aksu, B; Alpay, H; Atmis, B; Aydog, O; Bayazit, AK; Bayram, MT; Bilge, I; Bulut, IK; Buyukkaragoz, B; Comak, E; Demir, BK; Dincel, N; Donmez, O; Durmus, MA; Dursun, H; Dusunsel, R; Duzova, A; Ertan, P; Gedikbasi, A; Goknar, N; Guven, S; Hacihamdioglu, D; Jankauskiene, A; Kalyoncu, M; Kavukcu, S; Kenan, BU; Kucuk, N; Kural, B; Litwin, M; Montini, G; Morello, W; Nayir, A; Obrycki, L; Omer, B; Ozdemir, EM; Ozkayin, N; Paripovic, D; Pehlivanoglu, C; Saygili, S; Schaefer, S; Sonmez, F; Tabel, Y; Tas, N; Tasdemir, M; Teixeira, A; Tekcan, D; Tulpar, S; Turkkan, ON; Uysal, B; Uysalol, M; Vaiciuniene, D; Yavuz, S; Yel, S; Yildirim, T; Yildirim, ZY; Yildiz, N; Yuksel, S; Yurtseven, E; Schaefer, F; Topaloglu, R (NOV)

    • COVID-19 in pediatric nephrology centers in Turkey 

      Leventoglu, E; Ozdemir Atikel, Y; Nalcacioglu, H; Dursun, I; Dursun, H; Yuruk Yildirim, Z; Yildiz, N; Kaya Aksoy, G; Tasdemir, M; Celakil, M; Demircioglu Kilic, B; Zirhli Selcuk, S; Canpolat, N; Kargin Cakici, E; Ozlu, SG; Tulpar, S; Yuksel, S; Atmis, B; Surmeli Doven, S; Taner, S; Ertan, P; Kavaz, A; Torun Bayram, M; Kalyoncu, M; Gulleroglu, K; Kabasakal, C; Kasap Demir, B; Cicek, RY; Bilge, I; Donmez, O; Kara, A; Yavascan, O; Ozcelik, G; Gezgin Yildirim, D; Guler, MA; Sonmez, F; Poyrazoglu, H; Akman, S; Topaloglu, R; Alpay, H; Bakkaloglu, SA (2022)
      Background/aim: There is limited data on COVID-19 disease in children with kidney disease. We aimed to investigate the characteristics and prognosis of COVID-19 in pediatric nephrology patients in Turkey. Materials and ...

    • COVID-19: vaccination vs. hospitalization 

      Uzun, O; Akpolat, T; Varol, A; Turan, S; Bektas, SG; Cetinkaya, PD; Dursun, M; Bakan, N; Ketencioglu, BB; Bayrak, M; Baris, SA; Guner, R; Gunal, O; Nural, S; Deniz, PP; Toprak, OB; Ozkan, G; Gumus, A; Kerget, F; Ercelik, M; Ataoglu, O; Yuksel, A; Ates, G; Kutsoylu, OE; Kose, N; Kizilirmak, D; Keskin, S; Gultekin, O; Coskun, N; Yilmaz, ES; Uslu, S; Basyigit, I; Ergan, B; Deveci, F; Yakar, MN; Zuhur, C; Sagcan, G; Yuce, ZT; Kuluozturk, M; Sezgin, ME; Sezgin, ENA; Havlucu, Y; Cuhadaroglu, C; Kilinc, O; Boyaci, H; Altunay, H; Akti, M; Dursun, ZB; Kalem, AK; Isik, SA; Akyildiz, L; Aykac, N; Almaz, MS; Kokturk, N; Itil, O (JUN)
      Objective Vaccination is the most efficient way to control the coronavirus disease 2019 (COVID-19) pandemic, but vaccination rates remain below the target level in most countries. This multicenter study aimed to evaluate ...

    • Development of ASAS quality standards to improve the quality of health and care services for patients with axial spondyloarthritis 

      Kiltz, U; Landewe, RBM; van der Heijde, D; Rudwaleit, M; Weisman, MH; Akkoc, N; Boonen, A; Brandt, J; Carron, P; Dougados, M; Gossec, L; Jongkees, M; Machado, PM; Marzo-Ortega, H; Molto, A; Navarro-Compan, V; Niederman, K; Sampaio-Barros, PD; Slobodin, G; van den Bosch, FE; van Tubergen, A; van Weely, S; Wiek, D; Braun, J (FEB)
      Objectives The Assessment of SpondyloArthritis International Society (ASAS) aimed to develop a set of quality standards (QS) to help improve the quality of healthcare provided to adult patients affected by axial spondyloarthritis ...